Human monoclonal antibody human CD134 (OX40) and methods of making and using same
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 9, 2012
Grant Date -
Aug 5, 2010
app pub date -
Nov 27, 2006
filing date -
Nov 25, 2005
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention provides antibodies that specifically bind to OX40 (CD134), referred to as OX40 antibodies, anti-OX40 or anti-OX40 antibodies. Invention antibodies that specifically bind to OX40 include mammalian (human, primate, etc.), humanized and chimeric anti-OX40 antibodies. Invention antibodies and antibody subsequences (fragments) that specifically bind to OX40 include purified and isolated antibodies, as well as pharmaceutical formulations thereof, are useful in various methods including treatment, screening and detection methods.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully